IL140580A0 - Isoflavonoid-based therapeutic composition intended to be used in the treatment of tumours with cytotoxic agents - Google Patents

Isoflavonoid-based therapeutic composition intended to be used in the treatment of tumours with cytotoxic agents

Info

Publication number
IL140580A0
IL140580A0 IL14058099A IL14058099A IL140580A0 IL 140580 A0 IL140580 A0 IL 140580A0 IL 14058099 A IL14058099 A IL 14058099A IL 14058099 A IL14058099 A IL 14058099A IL 140580 A0 IL140580 A0 IL 140580A0
Authority
IL
Israel
Prior art keywords
isoflavonoid
tumours
treatment
therapeutic composition
cytotoxic agents
Prior art date
Application number
IL14058099A
Other languages
English (en)
Original Assignee
Lafon Labor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lafon Labor filed Critical Lafon Labor
Publication of IL140580A0 publication Critical patent/IL140580A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
IL14058099A 1998-07-15 1999-07-13 Isoflavonoid-based therapeutic composition intended to be used in the treatment of tumours with cytotoxic agents IL140580A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9809059A FR2781154B1 (fr) 1998-07-15 1998-07-15 Composition therapeutique a base d'isoflavonoides destinee a etre utilisee dans le traitement des tumeurs par des agents cytotoxiques
PCT/FR1999/001715 WO2000003707A1 (fr) 1998-07-15 1999-07-13 Composition therapeutique a base d'isoflavonoïdes destinee a etre utilisee dans le traitement des tumeurs par des agents cytotoxiques

Publications (1)

Publication Number Publication Date
IL140580A0 true IL140580A0 (en) 2002-02-10

Family

ID=9528649

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14058099A IL140580A0 (en) 1998-07-15 1999-07-13 Isoflavonoid-based therapeutic composition intended to be used in the treatment of tumours with cytotoxic agents

Country Status (11)

Country Link
EP (1) EP1096929A1 (fr)
JP (1) JP2002520357A (fr)
KR (1) KR20020006510A (fr)
CN (1) CN1139383C (fr)
AU (1) AU761417B2 (fr)
BR (1) BR9912817A (fr)
CA (1) CA2337256A1 (fr)
EA (1) EA200100141A1 (fr)
FR (1) FR2781154B1 (fr)
IL (1) IL140580A0 (fr)
WO (1) WO2000003707A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6146668A (en) 1997-04-28 2000-11-14 Novogen, Inc. Preparation of isoflavones from legumes
AUPP260798A0 (en) 1998-03-26 1998-04-23 Novogen Research Pty Ltd Treatment of medical related conditions with isoflavone containing extracts of clover
AUPQ266199A0 (en) * 1999-09-06 1999-09-30 Novogen Research Pty Ltd Compositions and therapeutic methods involving isoflavones and analogues thereof
PL205635B1 (pl) * 2001-04-09 2010-05-31 Inst Farmaceutyczny Nowe pochodne genisteiny i zawierające je środki farmaceutyczne
ATE361746T1 (de) * 2002-03-06 2007-06-15 Medical Res And Education Trus Botanischer extrakt mit antikrebs-aktivität enthaltend isoliquiritigenin
AU2002951833A0 (en) 2002-10-02 2002-10-24 Novogen Research Pty Ltd Compositions and therapeutic methods invloving platinum complexes
DE10337863A1 (de) * 2003-08-18 2005-03-17 Merck Patent Gmbh Verwendung von Chromen-4-on-Derivaten
CA2590048C (fr) 2007-05-23 2013-07-16 Institut National De La Recherche Scientifique Analogues de nucleoside de cytosine et isoflavones et leurs utilisations
CN106265669A (zh) * 2016-08-04 2017-01-04 大连理工大学 大豆苷元与10‑羟基喜树碱的药物组合及其应用
CN113842387A (zh) * 2021-11-19 2021-12-28 大连理工大学盘锦产业技术研究院 10-羟基喜树碱与鹰嘴豆芽素a的药物组合物及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0617304B2 (ja) * 1982-09-09 1994-03-09 理化学研究所 制癌剤
US5506211A (en) * 1994-05-09 1996-04-09 The Uab Research Foundation Genistein for use in inhibiting osteroclasts
US5824702A (en) * 1996-06-07 1998-10-20 Mount Sinai School Of Medicine Of The City University Of New York Genistein as a preventive against ultraviolet induced skin photodamage and cancer
AUPO203996A0 (en) * 1996-08-30 1996-09-26 Novogen Research Pty Ltd Therapeutic uses
JP2829387B2 (ja) * 1996-09-13 1998-11-25 農林水産省四国農業試験場長 脂肪細胞における脂肪分解促進用組成物
GB9621757D0 (en) * 1996-10-18 1996-12-11 Ciba Geigy Ag Phenyl-substituted bicyclic heterocyclyl derivatives and their use
US5733926A (en) * 1996-12-13 1998-03-31 Gorbach; Sherwood L. Isoflavonoids for treatment and prevention of alzheimer dementia and reduced cognitive functions

Also Published As

Publication number Publication date
CN1312712A (zh) 2001-09-12
CN1139383C (zh) 2004-02-25
FR2781154A1 (fr) 2000-01-21
FR2781154B1 (fr) 2001-09-07
EP1096929A1 (fr) 2001-05-09
JP2002520357A (ja) 2002-07-09
AU4628299A (en) 2000-02-07
AU761417B2 (en) 2003-06-05
WO2000003707A1 (fr) 2000-01-27
KR20020006510A (ko) 2002-01-19
EA200100141A1 (ru) 2001-06-25
CA2337256A1 (fr) 2000-01-27
BR9912817A (pt) 2001-05-08

Similar Documents

Publication Publication Date Title
GB0106183D0 (en) Improvements in or relating to the treatment of lesions
HUS1500001I1 (hu) ET743 alkalmazása kombinációs terápiában dexametazollal rákbetegség kezelésére
HUP0203367A3 (en) Benzylidine-thiazolidinediones and analogues and their use in the treatment of diabetes
GB0004167D0 (en) 1-piperidinyl-propan-2-ol derivatives and their use as therapeutic agents
HK1028957A1 (en) Use of n,n-bis (phenylcarbamoylmethyl) dimethylammonium chloride and derivatives in the treatment of chronic pain
HK1074167A1 (en) Methods and compositions to determine the chemosensitizing dose of suramin used in combination therapy
IL140580A0 (en) Isoflavonoid-based therapeutic composition intended to be used in the treatment of tumours with cytotoxic agents
HUP0300917A3 (en) Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and pharmaceutical compositions containing them
IL140588A0 (en) Therapeutic composition based on flavonoids intended to be used in the treatment of tumours by cytotoxic agents
HUP0401484A3 (en) Use of bibn4096 in combination with other antimigraine drugs for the treatment of migraine and pharmaceutical compositions containing the combination
HUP0100350A3 (en) Conjugates useful in the treatment of prostate cancer, pharmaceutical compositions comprising thereof, process for their preparation and their use
HK1037517A1 (en) Use of apomorphine in the treatment of premature ejaculation
AU6814601A (en) Use of mutant herpes viruses and anticancer agents in the treatment of cancer
GB0316026D0 (en) Compositions containing gangliosides for use in the treatment of skin disorders
EP1003516A4 (fr) Administration de composes camptotheciniques de cancerotherapie avec reduction de leurs effets secondaires
IL147410A0 (en) L-acetylcarnitine and l-propionylcarnitine containing composition for the prevention and treatment of kidney dysfunctions and diseases
AU2001233811A1 (en) Combined use of chemokine ip-10 and interleukin 12 in the preparation of compositions for the treatment of malignant tumors
EP1583543A4 (fr) Procedes et compositions therapeutiques pour le traitement d'un cancer avance
HUP0105203A3 (en) S-nitrosothiols as agents for the treatment of circulatory dysfunctions and their use
EE200200348A (et) Ravimkoostis kasutamiseks valu ravis
MXPA02005649A (es) Nuevas combinaciones terapeuticas de (s)-2 -(bencilamino -metil)-2, 3, 8, 9-tetrahidro-7h -1, 4-dioxino(2-3 -e]indol-8 -ona y agentes neurolepticos para el tratamiento o prevencion de trastornos psicoticos.
AU2001223910A1 (en) Interferon-alpha use in the treatment of ewing's family of tumors
PL351958A1 (en) Treatment of some tumours associated with gain in weight
KR100511819B1 (en) Compositions and Methods for the Treatment of Tumor
GB9827245D0 (en) Improvements in or relating to the treatment of lesions